Gustavo A. Rosario Benitez

Array ( [id] => 6518695 [patent_doc_number] => 20100216977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'THERAPEUTIC AGENT FOR INTERSTITIAL PULMONARY DISEASE COMPRISING ANTI-HMGB-1 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/449562 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22906 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216977.pdf [firstpage_image] =>[orig_patent_app_number] => 12449562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631236 [patent_doc_number] => 20100173277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Agent for Suppressing Rejection in Organ Transplantation Comprising Anti-HMGB-1 Antibody' [patent_app_type] => utility [patent_app_number] => 12/527159 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20114 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173277.pdf [firstpage_image] =>[orig_patent_app_number] => 12527159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422006 [patent_doc_number] => 20090148461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'ANTI FGF23 ANTIBODY AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/030593 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25543 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148461.pdf [firstpage_image] =>[orig_patent_app_number] => 12030593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418475 [patent_doc_number] => 20100167395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Humanized GM-CSF antibodies' [patent_app_type] => utility [patent_app_number] => 12/012028 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8501 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167395.pdf [firstpage_image] =>[orig_patent_app_number] => 12012028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5457875 [patent_doc_number] => 20090258027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Methods of modulating immune function' [patent_app_type] => utility [patent_app_number] => 12/011643 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33639 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258027.pdf [firstpage_image] =>[orig_patent_app_number] => 12011643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580492 [patent_doc_number] => 20090175838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'METHODS OF MODULATING IMMUNE FUNCTION' [patent_app_type] => utility [patent_app_number] => 12/021118 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33851 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175838.pdf [firstpage_image] =>[orig_patent_app_number] => 12021118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367123 [patent_doc_number] => 20090304682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Multiple-variable dose regimen for treating TNFa-related disorders' [patent_app_type] => utility [patent_app_number] => 12/008064 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 48034 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304682.pdf [firstpage_image] =>[orig_patent_app_number] => 12008064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807474 [patent_doc_number] => 20080171052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'HMGB1 PROTEIN INHIBITORSAND/OR ANTAGONISTS FOR THE TREATMENT OF VASCULAR DISEASES' [patent_app_type] => utility [patent_app_number] => 11/968506 [patent_app_country] => US [patent_app_date] => 2008-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6446 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171052.pdf [firstpage_image] =>[orig_patent_app_number] => 11968506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6479857 [patent_doc_number] => 20100092501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'FOXP3 PEPTIDE VACCINE' [patent_app_type] => utility [patent_app_number] => 12/522066 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16691 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092501.pdf [firstpage_image] =>[orig_patent_app_number] => 12522066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478525 [patent_doc_number] => 20100092423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/525442 [patent_app_country] => US [patent_app_date] => 2007-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2084 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092423.pdf [firstpage_image] =>[orig_patent_app_number] => 12525442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354677 [patent_doc_number] => 20090186021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents' [patent_app_type] => utility [patent_app_number] => 12/004382 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80848 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186021.pdf [firstpage_image] =>[orig_patent_app_number] => 12004382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284467 [patent_doc_number] => 20090098142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Methods and compositions for treating and monitoring treatment of IL-13-associated disorders' [patent_app_type] => utility [patent_app_number] => 12/001637 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 55674 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098142.pdf [firstpage_image] =>[orig_patent_app_number] => 12001637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725339 [patent_doc_number] => 08404454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Method for identifying a T-cell receptor protective against a disease' [patent_app_type] => utility [patent_app_number] => 12/745862 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11161 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6580732 [patent_doc_number] => 20100291054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NOVEL REGULATORY T CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/516891 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5949 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291054.pdf [firstpage_image] =>[orig_patent_app_number] => 12516891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739462 [patent_doc_number] => 20080233115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'ANTI-IL-20 ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 11/945975 [patent_app_country] => US [patent_app_date] => 2007-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81355 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233115.pdf [firstpage_image] =>[orig_patent_app_number] => 11945975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7728523 [patent_doc_number] => 08101178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Antibodies directed to tumor necrosis factor and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/876669 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35744 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101178.pdf [firstpage_image] =>[orig_patent_app_number] => 11876669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024271 [patent_doc_number] => 20110052597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/445753 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29460 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052597.pdf [firstpage_image] =>[orig_patent_app_number] => 12445753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 70864 [patent_doc_number] => 07754213 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'High affinity antibody antagonists of interleukin-13 receptor alpha 1' [patent_app_type] => utility [patent_app_number] => 11/875017 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 28328 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754213.pdf [firstpage_image] =>[orig_patent_app_number] => 11875017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5421998 [patent_doc_number] => 20090148453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Monoclonal antibodies against HMGB1' [patent_app_type] => utility [patent_app_number] => 11/974923 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 24665 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148453.pdf [firstpage_image] =>[orig_patent_app_number] => 11974923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832868 [patent_doc_number] => 20080131415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'ADOPTIVE TRANSFER OF CD8 + T CELL CLONES DERIVED FROM CENTRAL MEMORY CELLS' [patent_app_type] => utility [patent_app_number] => 11/870776 [patent_app_country] => US [patent_app_date] => 2007-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12192 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131415.pdf [firstpage_image] =>[orig_patent_app_number] => 11870776 [rel_patent_id] =>[rel_patent_doc_number] =>)